CSP403 - Trial of varicella zoster vaccine for the prevention of herpes zoster and its complications

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 06 May 2022

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

12 Apr 2016 Results (post hoc pooled analysis of this and other study, n = 28785) assessing severe injection-site and systemic AEs presented at the 26th European Congress of Clinical Microbiology and Infectious Diseases.
25 Oct 2008 Results published as an abstract in the proceedings of the 48th Interscience Conference on Antimicrobial Agents and Chemotherapy and 46th Annual Meeting of the Infectious Diseases Society of America.
01 Mar 2008 Results reported in the Journal of Infectious Disease.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com